|
|
| MRD / Regn No. |
: 20210000362 |
Date |
: 05/06/2026 |
| Patient Name |
: Amsavalli Jagannathan |
Age & Gender |
: 61 Yrs. / Female |
| Contact No. |
: 9629796917 |
UHID |
: |
| Ht / Wt / BMI |
: 157.5 / 57.9 / 23.34 |
BP S / BP D |
: / |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (10/Jul/2005) | NODULAR THYROID DISEASE (02/Mar/2021) | |
|
Subjective |
: |
CAD,DYSLIPIDEMIA,HAD CATARACT SURGERY,POST COVID 19,WAS TREATED FOR TB EFFFUSION,STEROID STOPPED,DYSESTHESIAS |
|
Objective |
: |
HAS GANGLION IN WRIST,NODULE IN R LOBE |
|
Analysis |
: |
ACR TIRADS 2 NODULE,T2DM STABLE |
|
Plan |
: |
SEE ME IN 1 MONTH,CONTINUE CURRENT MEDICATIONS |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 110 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 10 % | POST PRANDIAL GLUCOSE (2HPP): 192 mg/dL | NODULE 1 ACR TIRADS: 3 | NODULE 1 COMPOSITION: 1 | NODULE 1 DEPTH: 1.1 CM | NODULE 1 ECHOGENIC FOCI: 1 | NODULE 1 ECHOGENICITY: 1 | NODULE 1 HEIGHT: 1.2 CM | NODULE 1 LOCATION: LEFT | NODULE 1 USG TOTAL POINTS: 3 | NODULE 1 VOLUME: 0.9 cc | NODULE 1 WIDTH: 1.3 CM | NODULE 2 ACR TIRADS: 2 | NODULE 2 COMPOSITION: 1 | NODULE 2 DEPTH: 0.8 cm | NODULE 2 ECHOGENICITY: 1 | NODULE 2 HEIGHT: 1 CM | NODULE 2 LOCATION: RIGHT | NODULE 2 USG SCORE : 2 | NODULE 2 VOLUME: 0.5 cc | NODULE 2 WIDTH: 1.1 cm | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
28-0-22 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
INJECTION SEMAGLUTIDE
SEMALIX 0.25 MG
Medicine For DIABETES OBESITY MASLD CAD |
SQ |
ONCE A WEEK |
AS DIRECTED NO RELATION TO FOOD
|
TILL NEXT VISIT |
| MAY CAUSE NAUSEA VOMITING OR EYE DISTURBANCE | |
|
3 |
TABLET PREGABALIN SR 75 MG
PREGALIN SR 75 MG
Medicine For NEUROPATHY |
|
0-0-1 |
AT BEDTIME
|
1 MONTH |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: SMBG PREBREAKFAST AND PREDINNER |
| Next Visit |
: 05/Jul/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP HBA1C |
| |
|
| |
|
|
